本页面由Tiger Trade Technology Pte. Ltd.提供服务

Apimeds Pharmaceutical U.S, Inc.

5.20
+0.18003.59%
盘后:5.02-0.1800-3.46%19:59 EDT
成交量:140.35万
成交额:785.30万
市值:784.74万
市盈率:-0.13
高:6.04
开:5.43
低:4.97
收:5.02
52周最高:59.70
52周最低:1.51
股本:150.91万
流通股本:72.59万
量比:0.07
换手率:193.34%
股息:- -
股息率:- -
每股收益(TTM):-38.5450
每股收益(LYR):-0.1759
净资产收益率:-144.99%
总资产收益率:-69.29%
市净率:0.96
市盈率(LYR):-29.57

数据加载中...

2025/05/02

SEC问询函

Form CORRESP - Correspondence
2025/04/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/04/15

重要事件披露

Form 8-K - Current report
2025/02/10

SEC问询函

Form CORRESP - Correspondence
2025/02/10

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/02/10

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/02/08

SEC问询函

Form CORRESP - Correspondence
2025/02/08

SEC问询函

Form CORRESP - Correspondence
2025/02/06

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/29

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/10

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/12/20

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/12/20

SEC问询函

Form CORRESP - Correspondence
2024/12/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/11/08

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/25

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933